Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 1996

View Archived Issues

Merck & Co. describes new compounds for dopamine-related disorders

New bombesin analogues from Biomeasure

Takeda describes antiprotozoal agents

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Takeda discloses natural ET receptor antagonist

New serotoninergic drugs from E. Merck

Univ. of Washington offers human topo I-producing system for licensing

Discovery related to pharmacological screening and gene mapping available for licensing

Univ. of Washington offers cell line for screening compounds

Animal model for testing osteoporotic therapies available for licensing

Locus control region for transgenic expression available for licensing

3DP seeks partners for protease inhibitor discovery program

Partners sought for 3DP MHC blockers

3DP seeks partners for potential treatments for retinopathies and cancer

Corporate partners sought for drug discovery collaboration based on 3DP technology

3DP seeks partners for receptor-based drug discovery program

Anticancer compound from AEterna enters the clinic

Negative clinical results reported for aromatase inhibitor in BPH

Sorin to market Bard diagnostic test

DepoTech begins filing NDA for DepoCyt

Harvard Scientific seeks to proceed with clinical trials on erectile dysfunction Rx

Avigen reports successful gene therapy with EPO

Vertex compound effective in rat model of nerve injury

CytoTherapeutics and Genentech sign new CNS therapeutics agreement

Vasogen autocellular response therapy appears effective in RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...